Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases

Asia-Pacific Journal of Clinical Oncology

Volumn 10, Issue 2, 2014, Pages 118-123

  Bedard, Gillian ^a   Zeng, Liang ^a   Poon, Michael ^a   Lam, Henry ^a   Lauzon, Natalie ^a   Chow, Edward ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

BOMET QOL; Bone metastases; EORTC QLQ BM22; EORTC QLQ C30; Quality of life

Indexed keywords

ARTICLE; BONE METASTASES QUALITY OF LIFE QUESTIONNAIRE; BONE METASTASIS; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUEST; HEALTH CARE PERSONNEL; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; VALIDITY; WELLBEING; BONE TUMOR; METASTASIS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SECONDARY;

BONE NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84901426849     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12064     Document Type: Article

References (8)

1. Costa L, Badia X, Chow E, Lipton A, Wardley A. Impact of skeletal complications on patients' quality of life, mobility, and functional independence. Support Care Cancer 2008; 16: 879-889.
2. Chow E, Nguyen J, Zhang L etal. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 2012; 118: 1457-1465.
3. Chow E, Hird A, Velikova G etal. The European Organisation for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 2009; 45: 1146-1152.
4. Sureda A, Isla D, Cózar J etal. Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia. J Med Econ 2007; 10: 27-39.
5. Chow E, Bottomley A. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 461-465.
6. Chow E, Hoskin P, van der Linden Y, Bottomley A, Velikova G. Quality of life and symptom end points in palliative bone metastases trials. Clin Oncol (R Coll Radiol) 2006; 18: 67-69.
7. Harris K, Chow E, Zhang L etal. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. Eur J Cancer 2009; 45: 2510-2518.
8. Adrover E, Allepuz J, Sureda A. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL). J Outcomes Res 2005; 9: 15-27.